A phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in T3/T4a and/or lymph node-positive advanced adenocarcinoma of the esophagogastric junctio
Phase 2
Recruiting
- Conditions
- adenocarcinoma of the esophagogastric junction
- Registration Number
- JPRN-UMIN000020815
- Lead Sponsor
- Cancer Institute Hospital, Gastroenterological Chemotherapy Department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active synchronous or metachronous malignancy, excepting for early stage cancers 2) Active infectious diseases 3) Uncontrollable HBV infection 4) Pregnant or lactation women, or women with the possibility of the pregnancy. 5) Severe mental disorders, neurological disease 6) under systemic steroid therapy 7) under treatment of flucytosine, phenytoin or warfarin potassium 8) Iodoallergy 9) Unstable angina, or myocardial infarction within 6 months. 10) Patients who are judged inappropriate for the entry into this study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method